It is a risk reward decision that the great investors talk about all the time. What is the size of the market and potential upside on success ? IN this case it is enormous so the pay back could be many many multiples of the current market cap.
The question is does LER have the funding to reach its potential and is the product unique.
Personally I think it is early days but the potential reward for the risk we are taking is slanted to the upside and warrants the rocky road from idea to revenue to profitability to reward.
- Forums
- ASX - By Stock
- FGH
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-48
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FGH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.421M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
FGH (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online